SEC Comment Letter for Verastem, Inc. (VSTM) (CIK 0001526119) (VSTM) — Mar 30, 2020
Verastem, Inc. (VSTM) (CIK 0001526119)
Date: March 30, 2020 · CIK: 0001526119 · Accession: 0000000000-20-002729
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237332
Letter
March 30, 2020 Brian M. Stuglik Chief Executive Officer Verastem, Inc. 117 Kendrick Street, Suite 500 Needham, MA 02494 Re:Verastem, Inc. Registration Statement on Form S-1 Filed March 23, 2020 File No. 333-237332 Dear Mr. Stuglik: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Paul Fischer at 202-551-3415 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Thomas J. Danielski, Esq.
Show Raw Text
March 30, 2020
Brian M. Stuglik
Chief Executive Officer
Verastem, Inc.
117 Kendrick Street, Suite 500
Needham, MA 02494
Re:Verastem, Inc.
Registration Statement on Form S-1
Filed March 23, 2020
File No. 333-237332
Dear Mr. Stuglik:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Paul Fischer at 202-551-3415 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Thomas J. Danielski, Esq.